Stockwinners Market Radar for February 15, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:12 EST QuinStreet CEO sells $2.54M in common stock - In a regulatory filing, QuinStreet disclosed that its CEO Douglas Valenti sold 150K shares of common stock on February 13th in a total transaction size of $2.54M

20:04 EST Hamilton Lane opens office in Shanghai - Hamilton Lane "announced the official opening of its Shanghai, China office, underscoring the firm's commitment to the Asia Pacific region. This marks the firm's sixth location in the region, which includes offices in Hong Kong, Seoul, Singapore, Sydney and Tokyo."

19:02 EST VICI Properties enters lease agreement with Cherokee Nation on Tunica casino - The company states: "VICI Properties announced that, in connection with the acquisition of the operations of Gold Strike Casino Resort by CNE Gaming Holdings, L.L.C., an indirect subsidiary of Cherokee Nation Businesses, L.L.C., VICI has entered into a triple-net lease agreement with CNB with respect to the real property associated with Gold Strike. Initial total annual rent under the lease is $40.0 million and the lease has an initial term of 25-years with three 10-year tenant renewal options. Rent under the lease will escalate annually by 2.0%, and the tenant's obligations under the lease are guaranteed by CNB, the business holding company owned by Cherokee Nation, based in Oklahoma, the largest Native American tribe in the United States. "

18:19 EST Lottery.com names Mark Gustavson as new CEO - Lottery.Com has "appointed Mark Gustavson as CEO and principal executive officer, effective February 1, 2023. He will also serve as the principal financial/accounting officer of the company until a replacement is found. Gustavson replaced Sohail S. Quraeshi, who is no longer serving as Chief Executive Officer or as a principal executive officer of the company. On January 30, 2023, Edward K. Moffly resigned as interim CFO of the company. Gustavson is not a party to any material plan, contract or arrangement with the company, and there are no arrangements or understandings between Gustavson and any other person pursuant to which they were selected to serve as an officer of the company."

18:09 EST Morgan Stanley exec sells $6.96M in common stock - In a regulatory filing, Morgan Stanley disclosed that its Head of Wealth Management, Andrew Spaerstein sold 70.8K shares of common stock on February 13th in a total transaction size of $6.96M.

17:45 EST Cal Water receives approval for interim rate increases - California Water Service, a subsidiary of California Water Service Group, has received a ruling in its General Rate Case-pending before the California Public Utilities Commission-that approves modified interim rates effective beginning April 15, 2023. The ruling allows Cal Water to increase rates by 4% in most of its districts, so that the utility can continue to make infrastructure improvements intended to keep its systems safe and reliable. Interim rates are allowed by Administrative Law Judges in California when a final decision is delayed beyond the first day new rates were scheduled to be effective. In Cal Water's 2021 GRC filing, also known as its Infrastructure Improvement Plan, rates would have been effective on Jan. 1, 2023 had the CPUC issued a decision before then; however, that proceeding has been delayed. The ALJ had previously approved an interim rates memorandum account beginning Jan. 1, 2023 without a rate increase. Interim rates, which can reduce the compounded effect of delayed recovery, are subject to refund or adjustment depending on the final rates approved. "We appreciate the ALJ's understanding that inflation impacts Cal Water as well as our customers, and that withholding an interim rate increase could impact customers in the future by requiring higher surcharges on top of anticipated rate increases," said Martin A. Kropelnicki, Group President and CEO. "We are pleased that the CPUC acted to mitigate the impacts from a delayed decision."

17:35 EST Four Corners Property Trust acquires two Caliber Collision properties for $3.8M - Four Corners Property Trust announced the acquisition of two Caliber Collision properties for $3.8M. The properties are located in highly trafficked corridors in Illinois and are corporate-operated under long-term net leases with seven years of term remaining. The transaction was priced at a 6.7% cap rate on rent as of the closing date, exclusive of transaction costs.

17:22 EST Emergent announces FDA advisory committees vote in favor of OTC Narcan - Emergent BioSolutions announced the FDA Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee have unanimously voted in favor that the benefit-risk profile of Narcan Nasal Spray is supportive of its use as a nonprescription opioid overdose reversal agent. Emergent presented an overview of its over-the-counter, or OTC, development program, the medical need, Human Factors study data and seven years of post-marketing safety data. The FDA is not bound by the committees' guidance but will take its advice into consideration.

17:10 EST Royal Gold sees Q1 stream segment sales 54K-59K GEOs - Royal Gold expects stream segment sales of 54,000 to 59,000 GEOs for the quarter ended March 31, 2023, and expects to issue guidance for 2023 GEO sales, depreciation, depletion and amortization expense, and effective tax rate early in the second quarter of 2023.

17:09 EST Ampco-Pittsburgh subsidiary to increase base prices 10%-15% - Ampco-Pittsburgh announced that its subsidiary, Union Electric Steel Corporation will raise base prices 10%-15% on all forged and cast roll products that it and its subsidiaries produce globally. This increase is effective on all new quotations and new orders. Material and energy surcharges will remain in effect. The price adjustments are driven by continued inflationary cost increases in all areas of our business that are not captured by a surcharge.

17:08 EST North American Construction raises annual dividend 25% to C$0.40 from C$0.32

17:02 EST Nutrien raises quarterly dividend by 10% to 53c per share - The dividend is payable on April 13, 2023, to shareholders of record on March 31, 2023.

17:02 EST Manulife raises quarterly dividend 11% to 36.5c per share - Manulife's board of directors announced an increase of 11% or 3.5c per share to its quarterly common shareholders' dividend resulting in a dividend of 36.5c per share on the common shares of Manulife, payable on and after March 20, 2023, to shareholders of record at the close of business on February 28, 2023.

16:52 EST Azure Power receives extension from NYSE to file FY22 annual report - Azure Power Global announced that it received a letter from the NYSE on February 14, notifying that the NYSE's Listings Operations Committee agreed to provide the Company with an additional trading period through July 15, subject to reassessment on an ongoing basis, to complete and file the Company's annual report on Form 20-F for the fiscal year ended March 31, 2022 with the SEC and any subsequent delayed filings pursuant to the NYSE's late filer rules outlined in Section 802.01E of the NYSE Listed Company Manual. The Company has been in ongoing cooperation and correspondence with the NYSE on the late filing issue. The NYSE notified the Company that it will closely monitor the Company's progress with the milestones and timing submitted to the NYSE. Failure to achieve these interim milestones could result in accelerated trading suspension prior to the end of the July 15 trading period.

16:47 EST Marathon Oil sees FY23 CapEx $1.9B-$2B - Marathon Oil announced a $1.9B-$2B capital expenditure budget for 2023, fully consistent with the company's disciplined capital allocation framework that prioritizes corporate returns and FCF generation. The 2023 program is expected to deliver $2.6B of adjusted FCF at a reinvestment rate of approximately 40%, assuming $80/bbl WTI, $3.00/MMBtu Henry Hub, and $20/MMBtu TTF. Marathon Oil expects to deliver maintenance-level total Company oil production of 190,000 net bopd at the midpoint of its 2023 guidance range. Total Company oil-equivalent production is expected to be 395,000 net boed at the midpoint of guidance, inclusive of downtime associated with a planned second quarter E.G. turnaround. During 2023, Marathon Oil plans to average approximately nine rigs and three to four frac crews, excluding joint venture-related activity. The company expects to run approximately four rigs and two frac crews in the Eagle Ford, including on its newly acquired acreage from Ensign. Marathon Oil has not assumed any U.S. cash federal income tax payments in its 2023 financial guidance.

16:46 EST Cinemark founder Lee Roy Mitchell to retire from board - Cinemark Holdings "announced that founder Lee Roy Mitchell, 85, stepped down from the Company's Board of Directors following a highly influential tenure spanning nearly 40 years. Lee Roy served on the Board since its inception and transitioned from Executive Chairman to member of the Board in 2022. Lee Roy and his wife, Tandy, founded Cinemark in 1984 and grew it to a global company with nearly 6,000 screens across 16 countries. Lee Roy served as Cinemark's CEO until 2006 and then transitioned to Executive Chairman, a position he held until 2022."

16:42 EST Newcrest Mining rejects acquisition bid by Newmont - Newcrest Mining (NCMGY) states: "Further to the ASX announcement dated 6 February 2023, the Newcrest Board provides the following update on its review of the conditional, non-binding and indicative proposal received from Newmont Corporation (NEM) on 5 February 2023. Under the Indicative Proposal, Newmont would acquire 100% of the issued shares of Newcrest by way of a scheme of arrangement, for 0.380 Newmont shares for each Newcrest share held. The Board has considered the Indicative Proposal and has unanimously determined to reject the offer as it does not represent sufficient value for Newcrest shareholders." Reference Link

16:38 EST Welltower, Retirement Unlimited announce partnership - Welltower and Retirement Unlimited announced a robust programmatic partnership in the senior living space. The partnership began when RUI assumed management of the former Fountains at Washington House in Alexandria, Va., on November 15, 2022. With the management change, RUI also unveiled the community's new name - Elance at Alexandria, which represents the first installment in RUI's new luxury brand of Elance communities. The management change is part of a new partnership between RUI and Welltower, a real estate investment trust focused on data-driven and relationship-based investing. Welltower maintains a distinguished history of establishing long-term partnerships with leading seniors housing operators to enable further growth, innovation, and continuously improving care levels. A significant expansion in the programmatic relationship between Welltower and RUI is expected in the coming months and years through a robust pipeline of acquisition, transition, and development opportunities. The partnership is expected to grow to over 20 communities in the near term spanning multiple states throughout the East Coast.

16:36 EST Nu Skin raises quarterly dividend to 39c per share - To be paid on March 8 to shareholders of record on Feb. 27.

16:34 EST Wyndham Hotels & Resorts raises quarterly dividend to 35c per share - Beginning with the dividend expected to be declared in first quarter 2023.

16:34 EST Host Hotels provides update on Hurricane Ian damage - The company said, "As previously discussed, Hurricane Ian caused significant damage at The Ritz-Carlton, Naples and Hyatt Regency Coconut Point Resort and Spa. The Hyatt Regency Coconut Point remained open to first responders and reopened to guests on November 7, 2022, as part of a phased reopening. The pool facilities reopening is currently in progress and targeted for completion by June 2023. The Ritz-Carlton, Naples remains closed, and the Company is targeting a phased reopening strategy beginning in summer 2023. The Company is still evaluating the complete property and business interruption impacts of the storm, but currently estimates the total property damage and remediation costs resulting from the storm to be approximately $200 million to $220 million, across all of the affected Florida properties. The Company is insured for $325 million per named windstorm, with a $15 million deductible, resulting in potential insurance recovery of approximately $310 million for covered costs. Provided planned reopening dates can be maintained, the Company believes this coverage should be sufficient to cover substantially all of the property remediation and reconstruction costs and the near-term loss of business. However, it is possible that the insurance coverage may not be sufficient to cover the entirety of the business interruption caused by the storm. As of February 15, 2023, the Company has received approximately $50 million of insurance proceeds related to these claims. The Company estimates that Hurricane Ian negatively impacted its full year revenues by approximately $39 million, of which $33 million was in the fourth quarter, All Owned Hotel RevPAR by 60 basis points, with a 220 basis points impact in the fourth quarter, and net income and Adjusted EBITDAre by $18 million, of which $15 million was in the fourth quarter. The impact also reduced full year operating profit margin under GAAP by an estimated 20 basis points, with an 80 basis points impact in the fourth quarter, and All Owned Hotel EBITDA margin by 10 basis points, with a 40 basis points impact in the fourth quarter."

16:33 EST Olympic Steel raises quarterly dividend to 12.5c per share from 9c - The dividend is payable on March 15, 2023, to shareholders of record on March 1, 2023.

16:31 EST Radian Group raises quarterly dividend 12.5% to 22.5c per share - Radian Group announced its plans to continue the return of capital to stockholders through an increased quarterly dividend. The company's Board of Directors approved a quarterly dividend of 22.5c per share, an increase of 12.5% from the previous quarterly dividend. The dividend is payable on March 15, 2023 to stockholders of record as of February 27, 2023. This is the fourth consecutive year the company has increased the quarterly dividend, with a total increase of 80% over the past three years. Chief Executive Officer Rick Thornberry commented, "I am pleased that Radian's financial strength and flexibility support this increase to our dividend and the continued return of capital to stockholders, while also positioning us to support our customers and future business growth."

16:27 EST Cisco jumps 8% to $52.13 after Q2 earnings beat and FY23 guidance raise

16:25 EST Roku jumps 12% to $71.00 after Q4 results and guidance

16:23 EST HF Sinclair names Tim Go as new CREO - HF Sinclair "announced the promotion of Tim Go to the position of Chief Executive Officer and President of HF Sinclair, effective May 9, 2023. In addition, effective February 16, 2023, the Board of Directors of HF Sinclair increased the size of the Board by one to thirteen, appointed Mr. Go as a non-independent director to the Board and appointed Mr. Go to serve on the Executive Committee of the Board. Mr. Go succeeds Michael C. Jennings, who currently serves as the Chief Executive Officer of HF Sinclair and will continue serving in that role through May 8, 2023. In order to facilitate an orderly transition of the Chief Executive Officer duties from Mr. Jennings to Mr. Go, on February 15, 2023, HF Sinclair announced that Mr. Jennings was appointed to the position of Executive Vice President, Corporate of HF Sinclair, effective May 9, 2023, and is expected to serve in that role through his currently planned retirement date of November 9, 2023."

16:21 EST Sprinklr names Jacob Scott as General Counsel - Sprinklr "announced that Jacob Scott has been appointed general counsel and corporate secretary, reporting directly to Founder and CEO Ragy Thomas, effective March 16, 2023. Dan Haley, Sprinklr general counsel and corporate secretary since 2019, is moving on to a new opportunity after March 15, 2023."

16:18 EST Amedisys partners with BlueCross BlueShield of Tennessee - Amedisys announced a new agreement with BlueCross BlueShield of Tennessee to provide members in Middle Tennessee with palliative care in the comfort of their homes. With this program, BlueCross BlueShield of Tennessee's members can receive palliative care in-person or via telehealth from Amedisys' clinicians including doctors, nurse practitioners and nurses at no additional cost.

16:14 EST Cisco raises dividend 3% to 39c per share - To be paid on April 26 to all stockholders of record as of the close of business on April 5.

16:13 EST Axcella announces FDA clears IND application for AXA1125 trial - Axcella Therapeutics announced its Investigational New Drug application to initiate a phase 2b/3 trial in the U.S. for AXA1125 in the treatment of Long COVID Fatigue has been cleared by the U.S. Food and Drug Administration. The company reported that it had received regulatory guidance from the FDA, supporting a trial that is designed to serve as the registration trial for patients with Long COVID Fatigue. The study design now has acceptance from both the U.S. and U.K. regulatory authorities. Last month, the company announced a regulatory path to registration of AXA1125 in the treatment of Long COVID Fatigue, and that it had received regulatory guidance from The Medicines and Healthcare products Regulatory Agency, the U.K.'s regulatory agency, supporting a single trial that could serve as the registration trial for patients with Long COVID Fatigue. The guidance from the FDA and the MHRA follows the company's submission of materials to both regulatory agencies including results from the Phase 2a randomized, double-blind, placebo-controlled investigation to evaluate the efficacy and safety of AXA1125 in patients with fatigue related to Long COVID. The study found that subjects who received AXA1125 experienced clinically and statistically significant improvement in mental and physical fatigue scores compared to placebo subjects. Consistent with the Ph2a trial, the Ph2b/3 trial will enroll participants who have had fatigue for at least 12 weeks after COVID-19 infection. The primary endpoint will utilize the same patient reported outcome tool, the Chalder Fatigue Questionnaire, to measure improvements in fatigue. Additional endpoints will evaluate improvements in physical function, quality of life, and ability to return to work. Participants will receive either placebo or AXA1125 for three months.

16:11 EST Equinix increases dividend 10% to $3.41 - Equinix announced that its board of directors has declared a quarterly cash dividend of $3.41 per share on its common stock, a 10% increase over the previous quarter. The quarterly common stock dividend will be paid on March 22 to shareholders of record on March 7.

16:10 EST Robinhood reports January assets under custody $74.7B - The company said, "Net Cumulative Funded Accounts (NCFA) at the end of January were 23.0 million, up approximately 60 thousand from December 2022(1). Monthly Active Users (MAU) at the end of January were 12.0 million, up 600 thousand from December 2022. Notional Trading Volumes - which are the primary driver of transaction revenues - were higher in January for equities, options, and crypto from December 2022. Equities were $46.0 billion (up 19%), Option contracts were 82.9 million (up 10%), and Cryptocurrencies were $3.7 billion (up 95%). Margin Balances at the end of January were $3.0 billion, down $0.1 billion from the end of December 2022. Cash Sweep Balances at the end of January were $7.1 billion, up $1.3 billion from the end of December 2022. Of the $7.1 billion, $6.0 billion were in Gold accounts, which were up $1.2 billion from the end of December 2022."

16:09 EST Amplitude names Christopher Harms as next CFO - Amplitude has appointed former Forescout executive Christopher "Criss" Harms as the company's next CFO. The news comes as current CFO Hoang Vuong plans to transition from the company. Vuong will remain at Amplitude in the interim to ensure a seamless handover. "As we enter our next stage of growth, I believe Criss is the perfect successor. He has a strong track record as a public company CFO, and I respect how he navigated Forescout's maturity journey after it entered the public markets. I look forward to working closely with him as we continue on our mission to help companies build amazing products, drive growth, and win their categories."

16:07 EST Roku reports 2022 active accounts at 70.0M vs. 60.1M in 2021 - Reports 2022 Streaming Hours up by 14.3 billion hours y/y to 87.4 billion and Average Revenue Per User grew to $41.68, up 2% y/y

14:56 EST LF Capital Acquisition II announces LOI for business combination - LF Capital Acquisition Corp. II announced that it has entered into a letter of intent, or "LOI," with a "target company" for a potential initial business combination. "The LOI is non-binding with respect to all its material terms, except with respect to provisions regarding a limited period of exclusivity. The Target Company is a US-based manufacturer in the packaging industry with industry-leading profitability serving diversified end markets and with an established and highly attractive, blue-chip customer base that are subject to multi-year contracts. Under the terms of the LOI, LF II and the Target Company intend to enter into a definitive agreement pursuant to which LF II and the Target Company would combine, with the former equityholders of both entities following the completion of the Business Combination holding equity in the combined publicly listed company. The completion of the Business Combination is subject to the completion of due diligence to LF II's satisfaction, the negotiation and execution of definitive documentation and satisfaction of the conditions contained therein, including (i) securing certain concurrent financing, (ii) completion of any required stock exchange and regulatory reviews and (iii) approval of the transaction by LF II's stockholders and the Target Company's stockholders. Accordingly, no assurances can be made by either party that the parties will successfully negotiate and enter into a definitive agreement, or that the proposed transaction will be consummated on the terms or timeframe currently contemplated, or at all," the company stated.

14:08 EST LF Capital Acquisition II Corp trading halted, news pending

13:50 EST HP announces Z by HP workstation desktop lineup - HP Inc. (HPQ) announced its new Z by HP high-performance workstation desktop lineup. HP said it is advancing hybrid workforce management with the HP Anyware Remote System Controller, a device that gives IT departments the management capabilities to support high performance devices from anywhere. The complex workflows in industries spanning media and entertainment, data science, and engineering mean increased time pressure and the need for more compute power to deliver faster results. They also highlight a need to iterate with remote teams and push creative boundaries to deliver more accurate results. The new Z by HP Z4, Z6, Z8, and Z8 Fury desktops, powered by Intel (INTC), deliver the scalable balance of CPU and GPU compute needed to fuel new levels of speed, accuracy, and creativity. "Z by HP is dedicated to delivering the best possible computing experience to fuel new levels of speed, accuracy, and creativity," said Jim Nottingham, Vice President and General Manager, Z by HP. "HP's design engineering, together with the power of Intel and NVIDIA, provide the performance, scalability, and security our customers require to meet their evolving needs."

13:40 EST Distoken Acquisition opens at $10.20, IPO priced at $10 per unit - Distoken Acquisition is offering 6M units priced at $10 per unit. Each unit consists of one share of common stock, one right to receive one-tenth of a share upon the completion of an initial business combination, and one warrant, exercisable at $11.50. The blank check company plans to target businesses in the tech industry with primary operations in Asia and enterprise values between $100M-$200M, but will not pursue a combination with any target business utilizing a VIE structure. Distoken Acquisition is listing on the Nasdaq under the symbol "DISTU." I-Bankers Securities is the sole bookrunner for the offering.

13:30 EST Norfolk Southern expanding area eligible for reimbursements in Ohio - Norfolk Southern provided an update on environmental monitoring and community assistance for the Village of East Palestine, Ohio. "As of the evening of February 14, Norfolk Southern has: Completed more than 400 in-home air tests in conjunction with the U.S. Environmental Protection Agency and other governmental agencies. In-home air monitoring has not detected substances related to the incident and does not indicate health risks; Implemented an extensive outdoor air monitoring program in the community. Thousands of data points have been collected, which continue to indicate no risk to health from incident-related substances. Air monitoring is also being conducted in the broader region outside of the Village of East Palestine; Actively sampling the Village of East Palestine's drinking water supply wells, drinking water system, and private wells in areas potentially impacted by the incident; Distributed over $1.5 million in direct financial assistance to more than 1,000 families and a number of businesses to cover costs related to the evacuation. Those include reimbursements and cash advancements for lodging, travel, food, clothes, and other related items; and established a $1 million fund available immediately to the community. After a further review of areas affected by the evacuation orders and following discussions with East Palestine leaders, the company announced today that it is expanding the geographic area eligible for reimbursements for costs and inconvenience related to evacuating the region. All East Palestine residents in the 44413 zip code are now eligible," the company stated in its update. Reference Link

13:23 EST Greenwave secures property for metal recycling facility in Cleveland, Ohio - Greenwave Technology has secured the property formerly occupied by JBI Scrap Processors on East 55th Street in Cleveland, Ohio to open a scrap metal recycling facility. The Company expects its Cleveland, Ohio facility will generate significant revenues and positive cashflows from operations during fiscal year 2023. The property has access to the adjoining railroad to easily transport the scrap metal it processes and hundreds of local businesses and individuals are accustomed to selling their metal scrap to facilities in the same vicinity on a regular basis.Greenwave is currently training employees on its processes and procedures, on-boarding the facility to the cloud-based enterprise resource planning software it utilizes, and expects to begin operations by February 28, 2023.

12:47 EST Airbus names Covestro's Thomas Toepfer as new CFO - Airbus has appointed Dr. Thomas Toepfer, to succeed Dominik Asam, as Chief Financial Officer. Toepfer, currently CFO of Covestro AG, will join Airbus on September 1. Dominik Asam will leave Airbus on March 3. Xavier Tardy, Executive Vice-President Finance for Airbus Defence and Space, "will ensure continuity during the interim period in addition to his current role."

12:03 EST Gray Television enter agreements with Marquee for television station swap - Gray Television announced that it has reached agreements with Marquee Broadcasting to swap television stations. Gray will sell KNIN, its Fox Network-affiliated television station in the Boise, Idaho, market, to Marquee. Currently, another broadcaster in the Boise market provides local news programming and back-office services for KNIN under a shared services agreement, subject to the ultimate control of Gray. Concurrently with the KNIN closing, Marquee will sell WPGA, its MeTV Network-affiliated full-power television station in the Macon, Georgia market, to Gray. At that time, Gray will own a full-power television station in every television market located in its home state of Georgia. Both transactions are expected to close in the second quarter of 2023 following receipt of regulatory and other approvals.

12:00 EST Hecla Mining falls -10.2% - Hecla Mining is down -10.2%, or -57c to $5.08.

12:00 EST Herbalife Nutrition rises 14.3% - Herbalife Nutrition is up 14.3%, or $2.48 to $19.84.

12:00 EST Roblox rises 25.4% - Roblox is up 25.4%, or $9.04 to $44.72.

11:52 EST Devon Energy keeping 'high bar' on potential M&A deals

11:35 EST Devon Energy expects to be 'active buyers of our stock' - Devon Energy, on its Q4 earnings conference call, said it expects to be "active buyers of our stock, especially if we see trading weakness relative to our peers."

11:03 EST Boeing CFO: 737 sold out through 2026, 787 sold out through 2025

11:02 EST Pinnacle Bankshares Corp raises quarterly dividend 11% to 20c per shae - Pinnacle Bankshares Corporation announced that its Board of Directors declared a cash dividend of 20c per share on February 14, 2023, payable March 10, 2023, to shareholders of record as of February 24, 2023.

10:56 EST Alvarium Tiedemann Holdings Inc trading halted, volatility trading pause

10:54 EST Boeing CFO sees 737 deliveries declining to low 20s in February - CFO Brian West is speaking at the Cowen Aerospace/Defense & Industrials Conference.

10:12 EST Loblaw to transition away from single-use plastic shopping bags across BC - Loblaw Companies announced that effective February 16, it will begin transitioning away from single-use plastic shopping bags at stores across British Columbia, including Real Canadian Superstore, Your Independent Grocer, Real Canadian Liquor Store, Extra Foods and PC Express.

10:09 EST Mountain Crest Acquisition Corp III trading halted, volatility trading pause

10:07 EST Spirit Airlines announces five new, nonstop routes from San Juan - Spirit Airlines announces the launch of five new, nonstop routes from Luis Munoz Marin International Airport. The expansion adds convenient and affordable flights to Atlanta, Chicago, Dallas, Detroit and Hartford, growing Spirit's Puerto Rico service from 11 destinations to 16 by June 2023. The carrier also announced it will increase flights between San Juan and Orlando to five flights daily and grow flights between San Juan and Baltimore, Fort Lauderdale and Newark to two flights daily.

10:04 EST Boeing announces agreements to purchase 5.6M gallons of SAF for 2023 - Boeing has agreements to purchase 5.6 million gallons of blended sustainable aviation fuel produced by Neste to support its U.S. commercial operations through 2023. These agreements more than double the company's SAF procurement from last year.The purchase agreements include supply of Neste MY Sustainable Aviation Fuel which is blended with conventional jet fuel at a 30/70 ratio to produce the blended SAF. Neste MY SAF is made from 100% renewable waste and residue raw materials, such as cooking oil and animal fat waste, and meets strict sustainability criteria. EPIC Fuels and Signature Aviation company will provide 2.3 million gallons and Avfuel will supply 300,000 gallons of this blended SAF for the Boeing ecoDemonstrator flight test program and the company's commercial sites in Washington state and South Carolina. Boeing is also purchasing an additional 3 million gallons of the same blended SAF from EPIC Fuels and Signature Aviation, generating emissions reduction credits for commercial deliveries, Dreamlifter and executive flights.

10:02 EST Entera Bio announces FDA acceptance of Type D meeting review for EB613 PTH - Entera Bio announced that a Type D meeting protocol review has been accepted by the U.S. FDA to provide responses by March 30th, 2023. The pivotal, Phase 3 study protocol is entitled "A 24-Month Phase 3, Randomized, Double-Blind, Global Multicenter Study Comparing the Effects of Oral hPTH Daily Tablets vs. Placebo on Bone Mineral Density in Postmenopausal Women with Osteoporosis." EB613 is the first oral, once daily mini tablet presentation of hPTH. EB613 met primary and secondary endpoints in a placebo controlled, dose ranging Phase 2 study in 161 postmenopausal women with low bone mass and osteoporosis. As part of its briefing documents for the Type D process, Entera has submitted its Phase 3 protocol which reflects the agreement reached during the Company's September 2022 Type C Meeting discussion with FDA that a single 24 month Phase 3 placebo-controlled study could support a New Drug Application submission under the 505(b)(2) regulatory pathway and (2) that Total Hip Bone Mineral Density could serve as the primary endpoint for the registrational study. The objective of Type D meeting review is to confirm that the protocol fully meets FDA's expectations, including the analysis of the primary endpoint and the population PK evaluations, ahead of potential study initiation in H2 2023. The FDA previously agreed on major design elements of the protocol including the primary endpoint, enrollment criteria, titration and 2:1 randomization plan, and that 400 or more patients on EB613 is consistent with ICH E1A to support safety for the NDA. The current protocol reflects a 667/333 patient randomization, a 24 month total study duration and a futility interim analysis to occur when the last of the 300 first randomized subjects have completed 12 months in the study.

10:00 EST Clearwater Paper falls -11.5% - Clearwater Paper is down -11.5%, or -$4.24 to $32.53.

10:00 EST Sunlands Online falls -18.0% - Sunlands Online is down -18.0%, or -$2.34 to $10.67.

10:00 EST Herbalife Nutrition rises 10.5% - Herbalife Nutrition is up 10.5%, or $1.82 to $19.18.

09:58 EST European Commission to assess proposed acquisition of Figma by Adobe - In a posting on its Daily News page, the European Commission said it has accepted requests submitted by Austria, Belgium, Bulgaria, Cyprus, Czechia, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, and Sweden to assess under the EU Merger Regulation the proposed acquisition of Figma by Adobe, both of the US. The agency said, "Figma offers a web-based collaborative tool for product design, Figma Design, as well as a whiteboarding tool, FigJam. Adobe is a global software company offering, among others, an interactive product design tool, Adobe XD. The proposed transaction does not reach the turnover thresholds set by the EU Merger Regulation and therefore was not notified to the Commission. The transaction was notified for regulatory clearance in Austria and Germany, where it met national notification thresholds. Austria submitted a referral request to the Commission pursuant to Article 22(1) EUMR. This provision allows Member States to request the Commission to examine a concentration that does not have an EU dimension but affects trade within the single market and threatens to significantly affect competition within the territory of the Member States making the request. Other countries of the European Economic Area had the opportunity to join the original referral request. Subsequently, Belgium, Bulgaria, Cyprus, Czechia, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, and Sweden joined Austria's referral request.On the basis of the information provided by the referring countries, and without prejudice to the outcome of its full investigation, the Commission considers that the transaction meets the criteria for referral under Article 22 EUMR. In particular, the transaction threatens to significantly affect competition in the market for interactive product design and whiteboarding software, which is likely at least EEA-wide, and, therefore, in the referring countries. The Commission also concluded that it is best placed to examine the potential cross-border effects of the transaction. The Commission will now ask Adobe to notify the transaction. Adobe cannot implement the transaction before notifying and obtaining clearance from the Commission."[ Reference Link]:[https://ec.europa.eu/commission/presscorner/detail/en/mex_23_904]

09:53 EST Stellantis establishes new software hub in Poland - Stellantis N.V. is growing its software development and engineering network to eight hubs by establishing a new operation in Poland, the company said in a statement. The Poland software hub will be staffed with up to 300 employees in data analytics and software development and validation, and will be located in Gliwice, near a Stellantis manufacturing plant. The team in the Poland software hub will primarily focus on base software development, software application development, DevOps and automated validation.

09:47 EST Lithia & Driveway falls -8.6% - Lithia & Driveway is down -8.6%, or -$24.29 to $257.01.

09:47 EST Barclays falls -9.2% - Barclays is down -9.2%, or -85c to $8.37.

09:47 EST Bausch + Lomb rises 12.8% - Bausch + Lomb is up 12.8%, or $2.18 to $19.16.

09:46 EST ASML discloses data misappropriation by former employee in China - ASML disclosed in its annual filing: "We have experienced unauthorized misappropriation of data relating to proprietary technology by a (now) former employee in China. We promptly initiated a comprehensive internal review. Based upon our initial findings we do not believe that the misappropriation is material to our business. However, as a result of the security incident, certain export control regulations may have been violated. ASML has therefore reported the incident to relevant authorities. We are implementing additional remedial measures in light of this incident."

09:22 EST American Resources' ReElement joins NAATBatt - American Resources Corporation has joined NAATBatt International, the premiere trade association of developers, manufacturers, suppliers and users of battery technology in North America.

09:19 EST Creative Realities announces second amendment to merger agreement - Creative Realities announced the amendment of its agreements related to its previous acquisition of Reflect Systems via merger on February 17, 2022, which, in part, extended the maturity date of the $2.5 million Secured Promissory Note by one year, from February 17, 2023 to February 17, 2024. On February 11, 2023, Creative Realities and RSI Exit Corporation executed an amendment to the $2.5 million Secured Promissory Note. The original terms of the note required the Company to pay to the Stockholders' Representative a balloon payment of $1.25 million, plus all accrued and unpaid interest, on its stated maturity date, February 17, 2023. The Note Amendment eliminated the balloon payment, extending the maturity date for a one-year period, to February 17, 2024. During the extended period, the Company will continue to make monthly principal payments of $104,166.67, and the annual interest rate on the outstanding principal increased from 0.59% to 4.60%, which will accrue and is payable in full on the new maturity date. On February 11, 2023, Creative Realities and Stockholders' Representative executed a Second Amendment to the Merger Agreement, which provided that, among other things, the cash merger consideration payable in the Merger should be reduced by $0.2 million, or the "Claim Amount," subject to a reduction in the Claim Amount to the extent that Reflect or Creative Realities receives payments of certain accounts receivable of Reflect. An employer retention credit of $0.2 million based on the operations of Reflect pre-Merger remains outstanding and will be paid to the Stockholders' Representative for the benefit of former Reflect stockholders upon receipt, subject to the offset rights of Creative Realities. In light of the possible collection of the ERC and the Note Amendment, the parties agreed that the Claim Amount would be reduced by the amount of any ERC received by Creative Realities or Reflect prior to the maturity date of the Secured Promissory Note. If the Claim Amount exceeds the remaining amounts payable under the Secured Promissory Note on any payment date, Creative Realities may reduce the amount of the Secured Promissory Note, and the Claim Amount will be reduced on a dollar-for-dollar basis. In light of the resolution of the Claim Amount, the parties agreed to release $250,000 of escrowed funds, plus interest, to the Stockholders' Representative, which was placed in escrow at the closing of the Merger. The parties also amended an escrow agreement to extend the period for which the escrow agent would accept monthly payments of the Secured Promissory Note until the extended maturity date, February 17, 2024.

09:15 EST Nocera announces financial model with path to $100M in revenue - Nocera provides additional clarity on its path to 100m in revenues through its innovative fish farm recirculating system. The company plans to open 10 major fish farms in the US. Each with the capacity to launch 500 Nocera RAS tanks each with a maximum capacity of 100 '000 lbs of catfish a year. At maximum capacity an entire farm would yield 50m lbs of fish a year. Each pound of fish currently sells for $2 to a fish processor. If processed by Nocera through Nocera's owned processor, each pound of fish would net $3 profit to the company. With each farm containing 500 tanks, the farm would generate 50m pounds of fish. 50m pounds of fish sold through existing processor relationships would net the company $100m in top line revenue and with current economics upwards of $60m in profit. In the US, the average person consumes 17 pounds of seafood a year with the entire US population consuming 6B pounds of seafood yearly and growing 5% year on year. A Nocera fish farm operating at maximum capacity would only account for 8.3% of the current US market. The company expects to announce further developments of its US large scale fish farm plan soon in a model that can be replicated in other states.

09:12 EST Seanergy Marine announces 1-for-10 reverse stock split - Seanergy Maritime announced that its Board of Directors has determined to effect a 1-for-10 reverse stock split of the Company's issued and outstanding shares of common stock, effective at the opening of trading on February 16, 2023. At the special meeting of the shareholders of the Company held on February 7, 2023, Seanergy's shareholders approved a reverse stock split by a ratio of not less than 1-for-8 and not more than 1-for-12 and granted the Board the authority to determine to effect the reverse stock split and the exact split ratio within this range. The Board approved the reverse stock split on February 9, 2023. In addition, the Company announced today that its Chairman and Chief Executive Officer, Stamatis Tsantanis, intends to purchase an aggregate of up to $1,000,000 in the Company's common shares in the open market, following the effective date of the reverse stock split. Stamatis Tsantanis, the Company's Chairman & Chief Executive Officer, stated: "We believe that the consolidation of Seanergy's outstanding number of shares will further increase investor outreach for our stock and attract long-term investors. In addition, we aim to resolve trading uncertainties by ensuring due compliance with Nasdaq's listing criteria and improving the marketability and liquidity of the Company's common stock. I am committed to further expand my own open market stock purchases, as I believe that our current share price is deeply undervalued. The recently completed initiatives to increase shareholder value, our substantial buybacks of our securities and sizeable cash dividends, lay a strong foundation for our future success. I have great confidence in the solid fundamentals and long-term prospects of Seanergy and the capesize dry bulk sector."

09:10 EST CSX board increases quarterly dividend 10% to 11c per share - CSX announced that the Company's Board of Directors approved a 10% increase in its quarterly dividend, from $0.10 to $0.11 per share. The new $0.11 quarterly dividend is payable on March 15, 2023, to shareholders of record at the close of business on February 28, 2023.

09:09 EST Celanese in drug delivery research pact with Johns Hopkins - Celanese announced an agreement with Johns Hopkins University Department of Ophthalmology to collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye. Direct administration of therapeutics to the suprachoroidal space is growing more common as an approach for the treatment of retinal disorders. Treatment currently consists of frequent ocular injections performed at the physician's office. A bioinert implant based on the VitalDose platform can provide sustained ocular drug delivery for greater than six months, providing an alternative approach for reliable, continuous dosing and reducing the treatment burden for the patient. The VitalDose Drug Delivery Platform independently has proven biocompatibility and achieves greater than six months release of mAbs, peptides, small molecules and RNAi therapeutics, making it suitable for delivering a variety of therapeutics used for ophthalmologic conditions

09:07 EST Figs announces Steve Berube joins as COO - FIGS (FIGS) announced that Steve Berube has joined FIGS as Chief Operating Officer. FIGS also announced that current COO, Devon Duff Gago, has been appointed as FIGS' Chief Business Development Officer, and will work with Mr. Berube to facilitate a successful transition. As COO, Mr. Berube will lead distribution and logistics, as well as inventory planning and customer experience. In her new role, Ms. Duff Gago will lead a number of the company's key growth initiatives, including International and TEAMS, which is FIGS' B2B platform that enables institutions to standardize and professionalize with FIGS as their uniform. Each executive will report to Trina Spear, Chief Executive Officer of FIGS. Mr. Berube joins FIGS after serving as Senior Vice President of Distribution and Logistics at Levi Strauss & Co. (LEVI). During his tenure, he developed a global distribution strategy and oversaw a network of 35 facilities worldwide, led all logistics and trade functions, implemented multiple warehouse management systems and created infrastructure to support operations on a global scale. He previously served as Senior Vice President of Distribution and Logistics at lululemon athletica inc., and in various operations roles at Cole Haan and Nike.

09:06 EST Brooge Energy, Siemens Energy announce partnership - Brooge Energy (BROG) announced a partnership through the company's subsidiary Brooge Renewable Energy with Siemens Energy (SMEGF) to build a PV solar farm to supply BRE's Green Hydrogen and Green Ammonia project in Abu Dhabi, United Arab Emirates at the World Government Summit 2023 taking place on February 13 - 15, 2023 in Madinat Jumeirah, Dubai, United Arab Emirates. Lina Saheb, Interim Chief Executive Officer, commented, "It is with great honor to announce our partnership with Siemens Energy at the World Government Summit 2023 as together we take a step toward a greener future. I look forward to working closely with the talented Siemens Energy team on this important project." BRE and SE partnership is aimed to build up to 650 MW solar PV plant to supply BRE's planned Phase 1 of the green ammonia project with renewable energy. Siemens Energy will serve as the Technical Partner to Brooge and exclusive provider of solutions including engineering, design procurement, and construction of up to a 650 MW solar PV plant including grid connection and operation and maintenance services. The two companies will partner to obtain the necessary project approvals from governmental agencies as a first step of the project.

09:03 EST NYSE to suspend trading immediately in Avaya, start delisting proceedings - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Avaya Holdings - ticker symbol AVYA - from the NYSE. Trading in the company's common stock will be suspended immediately. "NYSE Regulation reached its decision that the Company is no longer suitable for listing pursuant to Listed Company Manual Section 802.01D after the Company's February 14, 2023 disclosure that the Company has filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. In reaching its delisting determination, NYSE Regulation noted the uncertainty as to the ultimate effect of this process on the value of the Company's common stock. NYSE Regulation also noted that the Company's restructuring support agreement does not contemplate any recovery for holders of the Company's common stock. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company's securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff's decision," the Exchange stated. Reference Link

09:03 EST NRS expands to Canada - National Retail Solutions announced the expansion of its network to Canada. The NRS platform provides independent retailers, including convenience, tobacco, and liquor stores, with a purpose-built, integrated hardware and software solution. Store management tools include a price book, inventory management solutions, sales reports and statistics, vendor payments, remote operations management through the My NRS Store mobile app, in-store promotions, e-commerce, a customer loyalty program, and more. NRS will also offer its Canadian retail partners NRS Pay, a straightforward, low-cost credit card processing service. NRS Pay is free of long-term contracts, termination costs, and the pernicious hidden fees often charged by other credit card payment processors. NRS is currently deploying its POS terminals to select retailers in Toronto and plans to expand to other Canadian cities in the coming months.

09:02 EST Amazon.com, RingCentral enter strategic collaboration - RingCentral (RNG) announced a strategic collaboration with Amazon (AMZN) Web Services, or AWS, to help organizations accelerate their cloud journeys and transform their employee and customer communications. As part of the multi-year agreement, AWS will offer industry-leading RingCentral MVP and RingCentral Contact Center solutions to its customers, giving them access to a leading unified communications platform that integrates enterprise-grade team messaging, video meetings, and a market-leading cloud phone system, along with an award-winning Contact Center solution.

08:59 EST Aware to demonstrate mobile biometric solutions a Mobile World Congress - At MWC Barcelona, Aware will demonstrate its mobile biometric solutions that integrate into any onboarding or ongoing authentication process an organization may wish to offer. These solutions include Knomi, Aware's mobile biometric authentication framework for more established organizations looking to integrate biometrics into their own applications, and AwareID, Aware's SaaS solution for businesses of any size.

08:57 EST Hepsiburada says nine cross-dock points impacted by recent earthquake - D-MARKET Electronic Services & Trading d/b/a Hepsiburada announced its initial assessment of the impact of the earthquake on February 6, 2023 in the Republic of Turkiye, on its business and operations. The company said, " Hepsiburada would like to express its deepest condolences to the victims of the earthquake affecting ten cities located in the southeast region of the Republic of Turkiye and also, the northwest region of the Syrian Arab Republic. Our sincere hopes are for the earliest possible relief and recovery of all the affected regions. Based on an initial assessment, Hepsiburada believes none of its employees or outsourced employees have lost their lives as a result of the earthquake. Hepsiburada will continue to take every effort to provide all the relevant support needed to both its employees and outsourced employees, as may be necessary. Hepsiburada's physical buildings used as its Istanbul headquarters and offices, and its Gebze fulfillment center - where most of its employees are based, apart from those working remotely - are located outside of the earthquake zone and have been unaffected by the earthquake. Nine cross-dock points out of a network of 190 cross-docks, have been directly impacted and will have to be relocated at the earliest convenience. The relocation of these parcel transfer centers or their contents is estimated to cost up to USD 200,000 in 2023. Hepsiburada's total number of Active Merchants on the Marketplace who have their registered address in the affected ten cities is approximately 6,500 out of over 94,000 Active Merchants. Hepsiburada has advanced its payments that were due to be made to them for those sales that were already invoiced, by one week. As expected during natural disasters, Hepsiburada has observed a temporary decline in overall customer demand on its platform, and the number of orders received during the week starting February 6th, compared to the preceding week, as well as compared to the same week of the past year. Hepsiburada believes that this decline may have been caused by the loss of traffic and demand from those ten cities affected by the earthquake and its decision to put major marketing campaigns, events and media advertising on hold out of respect for the nationwide mourning. Hepsiburada anticipates that a recovery in customer demand may occur gradually once the situation stabilizes."

08:52 EST Mawson Infrastructure expands Midland, PA facility by 100% to 100MW - Mawson Infrastructure Group announces that it has installed 2 additional substation transformers at its 100 MW Midland, PA site. These transformers will power the second 50MW of capacity at the facility, capable of holding up to 29,400 miners and producing up to 3.5 exahashes per second when fully deployed . The site is expected to be fully operational in early Q2, 2023 with these transformers being the final piece of infrastructure required, connecting the previously built out poles and wires and is expected to double the Mawson Self-mining and hosting operations, once our modular data centers and ASIC miners are fully deployed.

08:50 EST Veracyte: Value of test for men with high risk prostate cancer validated - Veracyte announced that data published in the International Journal of Radiation Oncology, Biology, Physics demonstrate that the company's Decipher Prostate Genomic Classifier can improve risk stratification among men with clinically high-risk prostate cancer. The data, from a pre-specified analysis of three phase 3 trials, represent the first validation of any gene-expression biomarker on pre-treatment biopsy samples from prospective randomized trials, and suggest the Decipher test provides clinically useful prognostic information to help personalize shared treatment decision-making. Approximately 30% of men with newly diagnosed localized prostate cancer present with high-risk disease, meaning they have an increased risk of disease recurrence, metastasis and death compared to men with lower-risk disease. However, previous studies have shown that more than 70% of men with high-risk prostate cancer who receive standard-of-care definitive radiotherapy and long-term androgen deprivation therapy will never develop metastatic disease.

08:48 EST Fortress Biotech's Helocyte announces Phase 1 pilot study published in journal - Helocyte, a subsidiary company of Fortress Biotech, announced that data from a Phase 1 pilot study published in the American Journal of Hematology demonstrated the feasibility, safety, immunological response and potential efficacy associated with vaccination of a hematopoietic cell transplant donor with the cytomegalovirus, CMV, vaccine Triplex to enhance protective CMV-specific T cells in immunosuppressed recipients of allogeneic HCT. The investigator-initiated trial conducted at City of Hope analyzed the results of 17 CMV-seropositive recipients who received an HCT from a matched related donor vaccinated with Triplex prior to stem cell harvest and transplant. Triplex was well tolerated with limited adverse events in donors and recipients, all of whom experienced successful engraftment. On day 28 post-HCT, levels of functional CMV-specific CD137+CD8+ T cells were significantly higher in recipients of Triplex with vaccinated MRD versus those in an unvaccinated MRD control cohort. Memory CMV-specific T cell responses continued to steadily expand through one-year of follow up. Lindsay Rosenwald, M.D., Fortress' Chairman, President and Chief Executive Officer, said, "To our knowledge, the outcome of the trial is the first reported evidence of a safe, successful attempt to increase protective CMV-specific T cell immunity in CMV-seropositive HCT recipients through vaccination of a donor. The donor vaccination paradigm deployed in the trial represents a promising approach that may be applicable to a variety of HCT settings and could limit the use of antivirals which are often associated with severe adverse events and delayed immune reconstitution. We look forward to exploring this approach further in a planned Phase 2 trial. Triplex is currently the subject of multiple ongoing and planned clinical trials in HCT, solid organ transplantation, Human Immunodeficiency Virus and in combination with CAR-T therapy."

08:45 EST Freight Technologies launches Fr8TMS 3.0, new shipper platform - Freight Technologies announces the launch of a major update for its transportation management system. The new update is aimed at revolutionizing the commercial trucking industry by introducing logistics and transportation technology to move freight within the USMCA region, with a focus on cross-border shipping. The update includes several new features and improvements, such as better real-time tracking and monitoring of shipments, which will allow shippers to see exactly where their freight is at all times and to receive notifications if there are any delays or issues. "We are excited to introduce this new update to the Fr8TMS, which will revolutionize the commercial trucking industry. The new features and improvements will make it easier for shippers to move their freight, and it will also benefit carriers and drivers by connecting them with shippers looking to move their freight," said Javier Selgas, CEO of Freight Technologies.

08:42 EST SciSparc, Clearmind collaborate to strengthen IP portfolio - SciSparc (SPRC) announced today that as part of its ongoing collaboration with Clearmind Medicine (CMND), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, three provisional patent applications were filed by Clearmind with the United States Patent and Trademark Office, USPTO. The patent applications refer to novel proprietary combinations of lysergic acid diethylamide, LSD, psilocybin, and N,N-dimethyltryptamine, DMT, and SciSparc's Palmitoylethanolamide, PEA, the active ingredient of its proprietary CannAmide. Under this collaboration, three other patent applications have been filed by Clearmind with the USPTO for the combination of SciSparc's PEA with Clearmind's MEAI compound for the treatment of alcohol use disorder, treatment of cocaine addiction and treatment of obesity and its related metabolic disorders. "These new patent applications continue to support our findings of the major role CannAmideTM, our proprietary PEA formulation, plays in SciSparc's various proprietary combination treatments," said Oz Adler, Chief Executive Officer of SciSparc. "All our clinical and pre-clinical studies performed to date, in numerous diseases and conditions, indicated CannAmide(TM) ability to reduce doses while maintaining therapeutic efficacy and while increasing safety. We have great confidence in our collaboration with Clearmind and believe that together we can maximize the therapeutic effect of our products, potentially offering additional solutions for mental health problems with unmet needs that have limited effective solutions, if at all," continued Adler.

08:39 EST Immix's Nexcella enters U.S. GMP manufacturing agreement for NXC-201 trial - Nexcella, a subsidiary of Immix Biopharma, announced that it has entered into a manufacturing agreement with a well-known United States Good Manufacturing Practice, GMP, cell therapy manufacturer that will supply a US Phase 1b/2 clinical trial of NXC-201 in relapsed/refractory multiple myeloma and AL amyloidosis. As Nexcella plans to expand the ongoing Israel trial to the U.S., it is necessary to demonstrate that clinical trial drug supply has been secured when submitting an Investigational New Drug, IND, application to the U.S. Food and Drug Administration. This U.S. manufacturing site is expected to supply NXC-201 material for the Phase 1b/2 clinical trial in the U.S. following an IND submission to the FDA and approval. Over the coming months, Nexcella plans to initiate a pre-IND meeting with the FDA, submit an IND application to the FDA, and obtain IND approval for a Phase 1b/2 of NXC-201 in relapsed/refractory multiple myeloma and AL amyloidosis. We believe recently reported Phase 1b clinical data from the ongoing clinical trial in Israel supports expanding the NXC-201 trial to the U.S. "We are excited about our progress toward bringing NXC-201 to United States clinical sites. Securing clinical supply is a critical step in advancing NXC-201 toward a potential U.S. regulatory submission. We believe NXC-201 could become a best-in-class therapy for patients suffering from AL amyloidosis and multiple myeloma," said Gabriel Morris, President of Nexcella.

08:35 EST Datasea launches converged cloud SaaS product for China Mobile - Datasea announced that Hangzhou Shuhai Zhangxun Information Technology, a subsidiary of the Chinese operating company contractually controlled by the Company, has entered into a product cooperation agreement with China Mobile Software Technology Co, a subsidiary of China Mobile Communications, and the operator of China Mobile's cloud open market. Under the terms of the agreement, Shuhai Zhangxun will launch Converged Cloud SaaS Product on the cloud open market as a service provider. This agreement marks a significant milestone in Shuhai Zhangxun's continuous efforts to upgrade its core 5G messaging products and enhance its AI personalized service capabilities with platforms like its chatbot. Moreover, it further reinforces product functions, advantages and competitiveness.

08:33 EST Sera Prognostics' PreTRM test shows predictive efficacy in Avert trial - Sera Prognostics announced top-line results from the Avert Preterm Trial. Both co-primary outcomes-reduction of severe neonatal morbidity or neonatal death; and decreased length of neonatal hospital stay-met their endpoints, and the improvements in outcome with a PreTRM test-and-treat approach were statistically significant. Results are being prepared for publication in a peer-reviewed journal. The PreTRM Test was broadly developed and validated for prediction of spontaneous preterm birth in the U.S. in the Proteomic Assessment of Preterm Risk study. The trial evaluated the health benefit afforded to babies when pregnancies are screened with the PreTRM Test and physicians intervened based on those results.

08:32 EST GlycoMimetics:Uproleselan in RR study continues with original even trigger event - GlycoMimetics announced the independent Data Monitoring Committee, DMC, reviewed the interim utility analysis of its Phase 3 study of uproleselan in relapsed/refractory, R/R, acute myeloid leukemia, AML, and recommended the study should continue to the originally planned final overall survival event trigger. "We thank the independent DMC for its recommendation and are strongly encouraged as the blinded pooled survival data continues to show patients living longer than historical benchmarks. Going forward, survival duration for new events in the study will be greater than 14 months since the last patient was randomized, giving us confidence in the potential for uproleselan to improve outcomes for people living with R/R AML," said Harout Semerjian, Chief Executive Officer of GlycoMimetics. "We are proud to be advancing a novel treatment with significant potential to address the urgent unmet medical need in this acute leukemia, and we look forward to continuing the study to the originally planned final overall survival analysis, now expected within the first half of 2024."

08:30 EST Coherus, Junshi announce final OS results of JUPITER-02 Phase 3 trial - Shanghai Junshi Biosciences (SHJBF) and Coherus BioSciences (CHRS) today announced results of a final analysis of overall survival from the pivotal study JUPITER-02, a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab in combination with gemcitabine and cisplatin as the first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma. This final analysis demonstrated a statistically significant and clinically meaningful improvement in OS in NPC patients treated with toripalimab plus chemotherapy compared to chemotherapy alone. These data are being submitted for presentation at an upcoming medical meeting. "In the pivotal JUPITER-02 trial, toripalimab has demonstrated a statistically significant and clinically meaningful overall survival benefit for patients with advanced NPC, an aggressive head and neck tumor with no current FDA-approved treatment options," said Rosh Dias, M.D., Coherus' CMO. "These mature overall survival data continue to demonstrate the benefit of toripalimab in the treatment of NPC patients, further building upon the data published in Nature Medicine and presented at the 2021 plenary session at the ASCO annual meeting, and clearly show that toripalimab has the potential to become the new standard-of-care for NPC patients, once approved. We look forward to sharing these data with the oncology community at an upcoming medical meeting."

08:26 EST Verses Technologies partners with SVT Robotics - VERSES Technologies announced a partnership with SVT Robotics, whose SOFTBOT Platform and partner ecosystem streamline the integration and deployment of robotics, IoT, and other industrial applications. SVT's integration with VERSES' network operating system, KOSM, is expected to accelerate deployments of AI powered robots into warehouses and distribution centers. By modeling enterprise data and processes as a multi-dimensional digital twin of each location, KOSM generates real-time intelligence, boosts worker productivity, and improves overall operational performance. A SOFTBOT connector for KOSM services will be available in SVT Robotics' AppDirectory for quick and reliable integration with any of the other automation and robotics technology connectors in the SVT ecosystem. This streamlines the integration and adoption of VERSES AI for use by supply chain companies using the latest logistics robots.

08:23 EST electroCore completes sale of New Jersey tax benefits - electroCore announced that it has completed the sale of its available tax benefits through the New Jersey Economic Development Authority's Technology Business Tax Certificate Transfer program. As a result, the Company has received approximately $211,000 in non-dilutive cash from the sale of these net operating loss, NOL, tax benefits. "We appreciate the support from the state of New Jersey through its NOL program, which we have benefited from over the past few years," stated, Brian Posner, Chief Financial Officer of electroCore. "This non-dilutive funding will continue supporting us as we invest in our growing business. We appreciate the support of New Jersey state leadership and the New Jersey Economic Development Authority, which has provided us with approximately $2.7 million of non-dilutive funding over the last three years."

08:22 EST Sylvamo in pact with shareowner Atlas, adds two new independent directors - Sylvamo's board of directors entered into a cooperation agreement with Atlas Holdings, its largest shareowner, adding two new independent directors to its board. Effective March 1, Sylvamo will add Karl Meyers and Mark Wilde, expanding the company's board to 11 directors. "We look forward to welcoming Karl and Mark to our board," said Jean-Michel Ribieras, chairman and chief executive officer. "They will bring valuable expertise to Sylvamo." The cooperation agreement includes customary restrictions and voting commitments. Sylvamo will nominate Meyers and Wilde for election with its other directors during its 2023 annual shareowners meeting. The board also determined it would terminate Sylvamo's shareholder rights plan immediately. The cooperation agreement and information about the shareholder rights plan will be included in a Form 8-K filed with the Securities and Exchange Commission.

08:19 EST Worksport announces $4M manufacturing line shipped to U.S. factory - Worksport announces that its $4M custom European manufacturing line has now begun the shipping process to the Company's wholly-owned 222,000 sq. ft. factory in Western N.Y., with an estimated arrival date of February 28th - one month earlier than initially anticipated. Upon its arrival, the Company anticipates that the installation and training process will take several weeks, after which the Company plans to conduct test runs. "The expected arrival of this machinery is much anticipated and will be a significant milestone for the Company," said Worksport CEO, Steven Rossi. "We are excited to begin installation and training so that production of our hard-folding tonneau covers can begin as soon as possible. We believe that will enable us to steer the Company toward our long-stated goal of revenue growth. We had looked into other potential solutions that might have allowed the Company to start production without this custom machinery, but there wasn't a viable alternative that we believe would enable us to meet our high standards for tonneau cover production" Rossi added. "If the installation of the new manufacturing line and training go as expected, we should be in full production with the hard-folding covers soon after. Then, we believe we will be well positioned to finish, test and perfect the Solis solar cover production line."

08:18 EST American Express opens Centurion Lounge at Seattle-Tacoma International Airport - American Express opened a new, 14,000 square foot Centurion Lounge at Seattle-Tacoma International Airport, or SEA. The new lounge is nearly triple the size of the original Centurion Lounge at SEA and now located in the newly created mezzanine level of the Central Terminal post-security. It features spectacular views of the airfield and iconic Olympic mountains, ample room for guests to relax or work before their flight, and a locally-inspired menu from Seattle-based Communion Restaurant and Bar Executive Chef Kristi Brown. Plus, the new location includes "Blue Roast by American Express," a coffee bar serving specialty coffee, espresso drinks, and cold brew from local Seattle roaster Caffe Umbria, and a one-of-a-kind mural of the Seattle skyline made from coffee beans by celebrated artist Harold Caudio.

08:17 EST Galera announces FDA acceptance, priority review of Avasopasem NDA - Galera Therapeutics announced that the U.S. Food and Drug Administration has accepted for filing and granted priority review to the New Drug Application for avasopasem manganese for radiotherapy-induced severe oral mucositis in patients with head and neck cancer undergoing standard-of-care treatment. There are currently no FDA-approved drugs to reduce SOM for these patients. With the 6-month priority review designation, the Prescription Drug User Fee Act target date assigned by the FDA for this NDA is August 9, 2023. The FDA indicated in its acceptance of filing letter that it is not planning to hold an advisory committee meeting on the application. The FDA previously granted Breakthrough Therapy and Fast Track designations to avasopasem for the reduction of SOM induced by RT.

08:16 EST Hologic announces approval of NovaSure V5 GEA device in Canada, Europe - Hologic has announced approval of the NovaSure V5 global endometrial ablation, or GEA, device in Canada and Europe. This new version incorporates enhanced features designed to treat a wide range of cervical and uterine anatomies. It builds on a track record for NovaSure, including 3M patients who have benefited from the device.

08:14 EST Tritium to add over 250 jobs at Lebanon, Tennessee factory - Tritium DCFC announced that the Company will be adding more than 250 jobs to the total anticipated workforce at its Lebanon, Tennessee factory. The Company also shared the recent achievement of International Organization for Standardization certifications at the facility. The 250+ jobs included in this announcement will add to the more than 500 jobs over the next five years in Lebanon, Tennessee that the Company announced in February 2022.

08:13 EST ProPhase Labs to expand Pharmaloz Manufacturing subsidiary - ProPhase Labs provided a business update with respect to its wholly-owned contract manufacturing subsidiary, Pharmaloz Manufacturing. To meet the growing demand for its products and services, Pharmaloz is acquiring new equipment which is expected to double its current capacity for pouch packaging by the second quarter of 2023. Pharmaloz is also planning for expansion of its lozenge manufacturing business. Altogether, these expansion initiatives are expected to lead to a 200% increase in capacity for 2024 as compared to 2022. It is currently expected that the Pharmaloz expansion will be funded entirely from internal cash flow generated from profits generated at the operating subsidiary level with no capital required from the parent company. Pharmaloz had two new customers enter full production in 2022, resulting in the addition of over 3.5 million units, mostly in the fourth quarter of 2022. The company formulated and launched seven new products for new and existing customers, totaling 1.75 million units. Additionally, the company added three new customers which are expected to enter full production in 2023, representing an estimated 1.0 million additional units. Pharmaloz brought customer micro testing in-house in 2022 and produced over 50 R&D sample runs for customers. Following these successful sample runs, the company is currently finalizing a contract with a potential new customer that could add over 6.0 million units per year and negotiating with another potential new customer that could add an additional 6.0 million or more units per year. Pharmaloz is also in the early stages of discussing options with four other potential new customers and is currently formulating liquid-filled lozenges for its customers, with additional equipment for these products expected to be added to its current production line in 2023.

08:12 EST Nuvve Holding engages ShareIntel to combat short selling activity - Nuvve Holding has entered into a service agreement with Shareholder Intelligence to assist in efforts to identify and combat suspected illegal naked short selling activities and other potential trading violations or market manipulation. Among other services, ShareIntel will monitor trading activity, including shareholder, critical broker-dealer and clearing firm trading patterns. Nuvve believes it may have been the target of a market manipulation scheme involving illegal naked short selling of its common stock that may have artificially depressed its share price and has engaged ShareIntel to monitor and investigate. ShareIntel utilizes a patented process called DRIL-Down to aggregate and analyze repository data from reporting entities, broker-dealers and shareholders.

08:11 EST Chinook Therapeutics appoints Andrew Oxtoby as CCO - Chinook Therapeutics announced the appointment of Andrew Oxtoby as chief commercial officer. He joins Chinook from Aimmune Therapeutics, where he most recently served as president and CEO and led the organization's integration into its new parent company, Nestle Health Science, and expanded Aimmune's portfolio and therapeutic focus beyond food allergy into disease states related to gastrointestinal conditions.

08:09 EST H2O Innovation appoints Leonard Graziano to board of directors - H2O Innovation announces the appointment of Leonard Graziano as a member of its Board of Directors, effective on February 13, 2023. Graziano has been serving on H2O Innovation's Strategy, Innovation and Large Projects Committee as an external advisor for the last six years. From 2002 to 2011, Graziano held the position of President and CEO of Severn Trent Services.

08:08 EST iQIYI enters framework agreement with Baidu on AI-generated content - iQIYI (IQ) has entered a framework agreement with Baidu (BIDU), connecting iQIYI to Baidu's generative dialogue product ERNIE Bot. Under the agreement, iQIYI and Baidu will jointly explore leveraging AI-Generated Content technologies on iQIYI's various business endeavors, including content search, promotion, novel creation and tools, among other areas. ERNIE Bot is a generative dialogue product Baidu launched based on its ERNIE technology. iQIYI would be given priority and internal access to trial ERNIE Bot. The technological capabilities will be deployed to facilitate the corporation between iQIYI and Baidu on production research and development, standard setting, and other areas.

08:06 EST Petco expands shop-in-shop partnership with Canadian Tire - Petco (WOOF) announced a significant expansion to its existing exclusive retail partnership with Canadian Tire (CDNAF). This expansion aims to enable Petco to further reach into Canada's assessed $5.3B pet market with an expanded, exclusive Petco product assortment in dedicated Canadian Tire store spaces as well as online. Petco shop-in-shops will be available in 90% of Canadian Tire's locations across the country by the middle of 2023. The shop-in-shop experience will also feature a variety of additional Petco brands.

08:04 EST Chipotle to open new restaurant called Farmesa in Santa Monica - Chipotle Mexican Grill announced it is opening a new restaurant called Farmesa at Third Street Promenade in Santa Monica, California. Farmesa is a fresh, bold concept featuring delicious proteins, greens, grains and vegetables that are inspired by Chipotle's Food with Integrity standards. The concept will soft open with an abbreviated menu and limited hours before officially rolling out next month.

08:02 EST Eminence Capital to vote AGAINST Ritchie Bros. proposed merger with IAA, Inc. - Eminence Capital, the beneficial owner of more than 900,000 shares of Class A Common Stock of Ritchie Bros. Auctioneers (RBA), announced its intention to vote AGAINST the company's proposed merger with IAA, Inc. (IAA). Eminence also issued a letter to RBA shareholders highlighting the flawed and risky nature of the transaction with limited strategic logic.

07:47 EST Jacobs selected for urban development project in Saudi Arabia - Jacobs and Jasara have been appointed by NEOM Company for The Line, its linear and cognitive city under development in the northwest of Saudi Arabia. A centerpiece for NEOM, The Line is designed to play a leading role in NEOM's aim of establishing itself as a new destination for global tourism, industry and innovation. Jacobs and Jasara will provide project and construction management consultancy services for the design, procurement, construction, testing and commissioning of The Line, together with the management of the critical interfaces between it and adjacent NEOM projects and logistics. The Line envisions a ribbon of hyper-connected, mixed-use communities completely powered by clean energy, where residents rely on ultra-high-speed transit, autonomous and personal mobility solutions and walking to access essential daily services.

07:40 EST PaxMedica anticipates multiple milestones in next 12-14 months - PaxMedica released a 2022 shareholder letter, which read in part, "2022 was an exciting year for PaxMedica. We reached several important milestones, and anticipate several others as we progress through 2023. PaxMedica's most important objective is to initiate PAX-101 clinical trials for the treatment of Autism Spectrum Disorder in the U.S. To achieve that primary objective, we are following a well-thought-out strategic path, comprised of key goals that will help accelerate us towards our primary objective. The past year was highlighted by our transition to a public company, after our Initial Public Offering in August 2022. This was an important milestone that will increase our corporate visibility, broaden awareness of PaxMedica in the investment community, and provide trading liquidity for our common stock. Thanks to our IPO, we raised $6.8 million in new capital. We have continued to raise capital for future operations and in November the company executed an equity investment agreement with Lincoln Park Capital, which will potentially provide up to an additional $20 million in working capital, giving the company a cash runway into 2025 based on our current operating plan, assuming we utilize the entire capacity of the Lincoln Park Capital facility. An important part of our strategy is to pursue an FDA program that provides valuable incentives for achieving an initial NDA approval as an orphan designated drug. One of the most critical steps in this process is a Phase 3 trial for HAT-301, that we initiated in November. This trial, which uses existing retrospective data that PaxMedica has exclusively licensed from key hospitals in Malawi and Uganda, is expected to advance PAX-101 towards FDA submission for the treatment of Stage 1 Trypanosoma Brucei Rhodesiense Human African Trypanosomiasis. This rare and fatal form of sleeping sickness has been the clinical target indication for suramin since it was first discovered in the early 1900s. We expect final results for the HAT-301 study in the second half of 2023. This is important because, if this trial is successful, we expect to seek accelerated approval for an NDA for PAX-101 as the first treatment for HATr approved under the U.S. Rare Tropical Disease Priority Review Voucher program. The Company expects to monetize a Priority Review Voucher, if received. We believe that this has the potential to be the fastest route to generate funding to complete a comprehensive clinical program for the use of PAX-101 for core symptoms of autism spectrum disorder and other neurodevelopmental conditions. We are in the process of establishing a commercial supply chain for PAX-101, which we expect to use for future regulatory filings, and future clinical needs...As you can see, PaxMedica made great strides in 2022 and we're poised to achieve a number of additional milestones over the next 12-24 months. With a strong management team, a lean cost structure, ample flexible funding, and a clear path forward, we believe that PaxMedica is well-positioned to achieve its goals."

07:38 EST ROC Energy Acquisition files registration form for business combination - ROC Energy Acquisition and Drilling Tools International, an oilfield services company that rents downhole drilling tools, announced that ROC filed a registration statement with the SEC on February 14, which contains a preliminary proxy statement/prospectus in connection with the proposed business combination between ROC and DTI. While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides information about ROC and DTI, as well as the proposed business combination. On February 13, ROC entered into a definitive agreement for a business combination with DTI. The transaction is expected to be completed in Q2 and is subject to approval by ROC's shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions.

07:36 EST Calyxt files Form S-4 in connection with merger with Cibus Global - Calyxt and Cibus announced that Calyxt has filed a registration statement on Form S-4 with the U.S. SEC on February 14. The combined company is expected to be renamed Cibus and remain listed on the Nasdaq Capital Market under the proposed ticker symbol CBUS. The Registration Statement contains a preliminary proxy statement / prospectus in connection with the previously announced merger of Calyxt and Cibus. Although the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Calyxt and the proposed transactions.The entering into a definitive merger agreement was announced on January 17. The merger is expected to close in the second quarter of 2023, subject to customary closing conditions, including approval of the merger by the shareholders of Calyxt.

07:34 EST Cboe Global Markets to launch Cboe One Options Feed - Cboe Global Markets announced it expects to launch the Cboe One Options Feed, beginning March 1, subject to regulatory approval. Through a single market data feed, the new data offering will provide a comprehensive, real-time view of U.S. options pricing derived from the largest U.S. options exchange operator. The new Cboe One Options Feed will deliver real-time quote and trade information consolidated from all four Cboe U.S. options exchanges by aggregating the best bid and offer of all displayed orders for equity, ETF and index options traded on the four exchanges.

07:25 EST Laser Photonics receives CDHR/FDA renewal approval for CleanTech products - Laser Photonics announced it recently received an annual approval by the Center for Devices and Radiological Health and the Food and Drug Administration, for its entire CleanTech line of products. With stringent regulations implemented by both the CDHR and FDA, Laser Photonics received accessions numbers 1911289-000 & 20R0078-000 covering its entire CleanTech line of products, achieving the gold standard for safety with laser-based cleaning systems.

07:23 EST Auddia appoints Tim Ackerman as CFO - Auddia announced the appointment of Tim Ackerman to the role of Chief Financial officer, CFO. Ackerman succeeds Brian Hoff, who resigned November 4, 2022, and has been serving as a consultant since his departure. Ackerman brings over twenty years of finance and operational experience in the software and services industry spanning both publicly traded and privately held companies. His Auddia appointment follows Premier Crop Systems where he served as Chief Financial Officer and board member prior to its sale in 2022.

07:22 EST Helius Medical showcasing PoNS Therapy at APTA CSM - Helius Medical will be showcasing its Portable Neuromodulation Stimulator technology at the American Physical Therapy Association Combined Sections Meeting At this year's CSM, Helius will not only inform on the benefits of PoNS Therapy but, for the first time, offer on-site training to teach physical therapists how to apply it. From Feb. 23-25, 2023, visitors to booth 1101 at the San Diego Convention Center will learn about Helius's PoNS device, which delivers electrical impulses through nerve fibers on the tongue, stimulating the flow of neural impulses to brain structures that control gait and balance. This cascade of activity results in a neuromodulatory effect, essentially "rewiring" parts of the brain and, when combined with exercise, helps people with MS improve their ability to walk.

07:20 EST Evoqua Water to divest carbon reactivation, slurry operations to Desotec - Evoqua Water announced that it has entered into a definitive agreement to divest its carbon reactivation and slurry operations to Desotec. The agreement, which includes the product line's workforce, reactivation facilities and associated equipment in Darlington, Pennsylvania, and Parker, Arizona, and the reactivation and carbon vessel manufacturing facility in Red Bluff, California, is expected to close during Evoqua's third quarter of fiscal 2023, which ends June 30, 2023, subject to customary terms, regulatory approvals, and closing conditions. Gross proceeds upon closing of the transaction are anticipated to be approximately $100M. The sale of the carbon reactivation and slurry business will allow Evoqua to focus on its core service business, which includes carbon services and the sale of high-quality activated carbon. After close, Evoqua will enter into a supply agreement with Desotec for reactivated carbon to continue to service its customers. Carbon is typically used in municipal and industrial applications to remove organic and inorganic contaminants from water sources.

07:19 EST SpringBig collaborates with Flowhub to introduce two-way loyalty integration - springbig introduced a new integration with Flowhub, the leading cannabis software company for dispensaries. The Company's latest feature utilizes Flowhub's Maui to simplify the checkout process, allowing customers to track their rewards on the go or in store. "springbig and Flowhub share a common goal of using technology to enhance the cannabis marketplace for retailers and consumers," said Jeffrey Harris, CEO of springbig. "The introduction of this integration will improve retail efficiency and allow customers to engage with the rewards program at their convenience."

07:18 EST Regulus acquires 70% interest in Colquirrumi claims - Regulus Resources announced that it has acquired a 70% interest in the Colquirrumi claims. The Colquirrumi claims will be held by a joint-venture with 70% belonging to Regulus and 30% belonging to Compania Minera Colquirrumi S.A., a wholly owned subsidiary of Buenaventura. Regulus will be the operator of the joint venture. The Colquirrumi claims represent approximately 2,571 hectares of mineral rights in a prolific mining district, adjacent to and interfingered with Regulus' AntaKori property. Regulus had the right to earn up to a 70% interest in the claims by completing 7,500 m of drilling. Buenaventura retained a one-time claw-back whereby it could retain a 70% interest in the claims by paying Regulus $9,000,000 and granting Regulus a 30% interest. Buenaventura did not elect to trigger its claw-back right. Less than 5% of the Colquirrumi claims have been properly explored, however several encouraging mineralized areas were discovered in Regulus' drill program. Selected highlights of the mineralization encountered can be found below: Hole AK-22-051: 171.95 m of 0.34% Cu, 0.39 g/t Au, 5.58 g/t Ag and 1.41% Zn from 337.35 m depth; 138.30 m of 0.23% Cu, 0.45 g/t Au and 4.27 g/t Ag from 588.90 m depth. Hole AK-22-050: 247.10 m of 0.34% Cu, 0.25 g/t Au and 9.58 g/t Ag from 283.20 m depth; 49.45 m of 0.58% Cu, 0.31 g/t Au and 19.72 g/t Ag from 418.90 m depth. Hole AK-21-047: 286.80 m of 0.29% Cu, 0.21 g/t Au and 7.70 g/t Ag from 383.80 m depth

07:17 EST Royalty Pharma sees FY23 adjusted cash receipts view $2.375B-$2.475B - Royalty Pharma expects 2023 Adjusted Cash Receipts(1) (non-GAAP) to be between $2,375 million and $2,475 million, excluding a potential $475 million milestone related to FDA approval of intranasal zavegepant and transactions announced subsequent to the date of this release. This guidance represents underlying growth of 4% to 9% prior to payments related to the Biohaven Preferred Shares in 2022.

07:14 EST Identiv enters exclusive agreement with Trace-ID - Identiv has signed an exclusive strategic agreement with Trace-ID, a Spain-based leading provider of UHF RFID technology and solutions, to become the exclusive provider for Trace-ID's complete line of specialty and industrial UHF RFID across North America.

07:11 EST AlloVir announces final results on posoleucel study to treatf BK viremia - AlloVir announced positive final results from a Phase 2 study of posoleucel, an investigational, allogeneic, off-the-shelf, multi-virus-specific T cell therapy, being studied for the treatment of BK viremia in adult kidney transplant recipients. The data support the safety and antiviral activity of posoleucel in this population, which has no effective BKV treatment options. In the randomized, double-blind, placebo-controlled study, posoleucel was shown to be generally well tolerated, with balanced safety across the two posoleucel dosing groups and placebo. Patients who received posoleucel achieved a clinically meaningful greater decline in BK viral load compared with those receiving placebo. The study results showed an even greater antiviral effect with posoleucel in patients with BK viral load =10,000 copies/mL at screening and in the biweekly posoleucel dosing group, identifying a dosing regimen and patient population to advance into a future trial. "BKV is one of the most feared transplant-associated viral infections, due to the lack of available effective antiviral therapies and its profoundly negative impact on transplant outcomes," said Anil K. Chandraker, M.D., Director of Renal Transplant Medicine, Brigham and Women's Hospital, and principal investigator of the posoleucel BKV treatment study. "The safety profile of posoleucel and its antiviral activity, which is amplified in high viral load patients who have the greatest unmet need, suggest it could potentially offer a transformative treatment option for kidney transplant patients with BK viremia." "

07:09 EST Analog Devices declares dividend of 86c per share - The ADI Board of Directors has declared a quarterly cash dividend of 86c per outstanding share of common stock. The dividend will be paid on March 8, to all shareholders of record at the close of business on February 27.

07:03 EST RedHill Biopharma announces positive FDA meeting regarding opaganib - RedHill Biopharma announced the positive outcome of a scheduled Type B meeting with the U.S. FDA for the development of opaganib for Acute Radiation Syndrome in which the FDA provided guidance on opaganib's developmental pathway to potential approval under the Animal Rule. "We are pleased to align with the FDA on the Animal Rule development pathway for opaganib for ARS. The FDA has provided very helpful guidance regarding the applicability in the case of opaganib of pivotal animal model efficacy studies in place of human clinical trials, and we plan to work closely with them to advance the development program in support of opaganib as a nuclear medical countermeasure," said Dr Mark Levitt, MD, PhD, Chief Scientific Officer at RedHill. "Given the promising data already generated with opaganib for ARS, we are set to continue collaborating with a range of U.S. agencies in addition to discussions with other governments."

06:59 EST Bausch + Lomb names Brent Saunders as CEO, succeeding Joseph Papa - Bausch + Lomb announced the appointment of Brent Saunders as CEO and chair of the Board of Directors of the company, effective March 6. Concurrent with this appointment, and as previously announced, Joseph Papa will step down from his roles as CEO and director. Additionally, effective upon Saunders' appointment as chair of the Board, Thomas Ross, Sr. will become the Lead Independent Director of the Board. To facilitate an orderly transition, Saunders will join Bausch + Lomb on Feb. 16 in an advisory capacity, where he will work closely with Papa. Saunders will return to Bausch + Lomb after having served at the company as CEO from 2010 to 2013. In total, he brings more than 25 years of leadership in health care, having served in president, CEO and chairman roles, among others, at several global pharmaceutical and health care companies, including Schering-Plough Corporation, Forest Laboratories Inc., Actavis plc, Allergan plc and The Beauty Health Company.

06:56 EST Aecom awarded contract by NAVFAC with $239M ceiling - Aecom announced that it has successfully been awarded a single-award, indefinite-delivery, indefinite-quantity contract by the Naval Facilities Engineering Systems Command Pacific to deliver architecture and engineering services for the Comprehensive Long-Term Environmental Action Navy Program. Under this contract with a $239M ceiling, Aecom will perform environmental studies, investigations, and designs that address pressing environmental challenges.

06:47 EST Choice Hotels sees FY23 adjusted EBITDA $520M-$540M - Sees FY23 net income $245M-$265M. Domestic RevPAR for full-year 2023 is expected to increase approximately 2%, compared to full-year 2022.

06:42 EST Taylor Morrison sees Q1 home closings 2,300-2,400 - Sees Q1 ending active community count 325-330. Sees Q1 effective tax rate 25%.

06:37 EST High Tide CFO Rahim Kanji to depart, Sergio Patino to succeed - High Tide announced today that the company and Rahim Kanji, CFO of the company, have mutually agreed to part ways effective February 28. To fill the vacancy following Kanji's departure, the company announced the appointment of Sergio Patino as interim CFO, effective February 28. He joined High Tide as a financial consultant in November of 2022 bringing more than 20 years of global experience across multiple industries.

06:34 EST Barrick Gold announces new $1B share repurchase program - Barrick Gold announced that it plans to undertake a new share repurchase program to buy back additional common shares. Barrick's board of directors has authorized a new program for the repurchase of up to $1B of the company's outstanding common shares over the next 12 months at prevailing market prices in accordance with applicable law. In connection with the new share repurchase program, Barrick has terminated the share repurchase program announced by the company on February 16. The company repurchased $424M in common shares under its 2022 share repurchase program.

06:31 EST Wabtec announces $750M share buyback plan, raises dividend 13% - Wabtec's Board of Directors announced a $750M share buyback reauthorization and a 13% increase in the quarterly dividend to 17c per share. The Board of Directors also declared a regular quarterly common dividend of 17c per share, payable on March 10 to holders of record on February 24.

06:12 EST Barrick Gold announces $1B share buyback program for next twelve months - Barrick's Board of Directors has authorized a new program for the repurchase of up to $1B of the company's outstanding common shares over the next 12 months at prevailing market prices in accordance with applicable law. In connection with the new share repurchase program, Barrick has terminated the share repurchase program announced by the company on February 16, 2022. The company repurchased $424M in common shares under its 2022 share repurchase program.

06:10 EST Maxar Technologies announces completion of "go-shop" period - Maxar Technologies announced the expiration of the 60-day "go-shop" period pursuant to the terms of the definitive merger agreement to be acquired by global private equity investors Advent International. Advent has agreed to acquire all outstanding shares of Maxar common stock for $53.00 per share in cash. During the "go-shop" period, Maxar and representatives of J.P. Morgan engaged with or actively solicited alternative acquisition proposals from 36 potentially interested third parties with respect to a possible alternative transaction to the merger. Maxar did not receive any competing acquisition proposals during the "go-shop" period. The transaction remains subject to the satisfaction of customary closing conditions, including approval by Maxar stockholders and receipt of regulatory approvals. The transaction received U.S. antitrust clearance at the end of January and remains on track to close in mid-2023. Upon completion of the transaction, Maxar's common stock will no longer be publicly listed, and Maxar will become a privately held company.

06:05 EST Hertz, BP to build national network of EV fast charging infrastructure - Hertz (HTZ) and bp (BP) are announcing their intention to build out a national network of EV fast charging infrastructure to accelerate the adoption of electric vehicles. Hertz and bp intend to bring charging infrastructure to Hertz locations across America, including major cities such as Atlanta, Austin, Boston, Chicago, Denver, Houston, Miami, New York City, Orlando, Phoenix, San Francisco, and Washington, DC. The charging hubs will serve rideshare and taxi drivers, car rental customers and the general public at high-demand locations, such as airports. bp aims to invest $1 billion in EV charging in the US by 2030. Hertz's objective is to make one-quarter of its fleet electric by the end of 2024.

06:04 EST White House announces progress for national network of EV chargers - The Biden-Harris Administration on Wednesday announced its latest set of actions aimed at creating a convenient, reliable and Made-in-America electric vehicle charging network so that the great American road trip can be electrified. These steps will help the United States meet President Biden's goals to confront the climate crisis, by building a national network of 500,000 electric vehicle chargers along America's highways and in our communities and have EVs make up at least 50% of new car sales by 2030, all while advancing an industrial strategy to continue to build-out the domestic EV and EV charging industry, The White House said in a statement. Companies including Tesla (TSLA), General Motors (GM), EVgo (EVGO), Pilot, Hertz (HTZ) and bp (BP), among others, are announcing new commitments to expand their networks by thousands of public charging ports in the next two years, using private funds to complement federal dollars and putting the nation's EV charging goals even closer within reach. Tesla, for the first time, will open a portion of its U.S. Supercharger and Destination Charger network to non-Tesla EVs, making at least 7,500 chargers available for all EVs by the end of 2024. Hertz and bp are announcing their intention to build out a national network of EV fast charging infrastructure to accelerate the adoption of electric vehicles. Pilot Company, General Motors, and EVgo have partnered to build a coast-to-coast network of 2,000 high power 350 kW fast chargers at Pilot and Flying J travel centers along American highways. TravelCenters of America (TA) and Electrify America announced that they will offer electric vehicle charging at select Travel Centers of America and Petro locations, with a goal of installing approximately 1,000 EV chargers at 200 locations along major highways over the next five years. General Motors, in partnership with FLO, has announced a collaborative effort with dealers to install up to 40,000 public Level 2 EV chargers in local communities by 2026 through GM's Dealer Community Charging Program. Ford (F) has committed to installing at least one public-facing DC Fast charger with two ports at 1,920 Ford dealerships by January 2024. Reference Link

05:22 EST Newmont COO Rob Atkinson to transition to new role, Natascha Viljoen to succeed - Newmont announced that Natascha Viljoen will join the company's executive leadership team as executive VP and COO upon completion of her notice period of up to 12 months. Viljoen has served as the CEO of Anglo American's platinum business in South Africa since 2020, the world's largest primary producer of platinum. Upon completion of the notice period and a planful transition, Rob Atkinson, executive VP and COO, will transition into a new role reporting directly to Tom Palmer, president and CEO.

05:15 EST Nokia, NTT Docomo and NTT announce two milestones on path to 6G - Nokia, NTT Docomo and NTT announced that they have achieved two technological milestones on the path to 6G. The first is the implementation of artificial intelligence, or AI, and machine learning, or ML, into the radio air interface, effectively giving 6G radios the ability to learn. The second is the utilization of new sub-terahertz, or sub-THz, spectrum to dramatically boost network capacity. The AI-native air interface and sub-THz spectrum are both critical research topics that Nokia, Docomo and NTT are exploring for future 6G networks. These technologies could pave the way for new immersive metaverse and extended reality, or XR, experiences and a new generation of mobile applications. The companies have implemented both technologies as proofs of concept at Nokia Bell Labs in Stuttgart, Germany, and Nokia and Docomo will demonstrate both technologies at Mobile World Congress in Barcelona, Feb. 27 - March 2. By pairing a AI-based learned waveform in a transmitter with a deep-learning receiver, Nokia Bell Labs, Docomo and NTT researchers were able to design and implement a learning air interface that transmits data efficiently under many different scenarios. This AI/ML-based implementation significantly reduces signaling overhead, producing up to a 30% improvement in throughput. In addition, the AI-native air interface will grant 6G networks the flexibility to adapt to the type of connection demanded by an application, device or user. For instance, a network in a factory can be optimized for industrial sensors at one moment and then reconfigured for robotic systems or video surveillance. In the public network, an AI-enhanced network can provide an optimized connection for a pedestrian in an XR session as well as an emergency vehicle traveling at high speed. Nokia, Docomo and NTT first launched their 6G collaboration in June, 2022, with the aim of jointly defining and developing key technologies for the next generation of networking.